Company / Net Debt per Share
Arcutis Biotherapeutics, Inc. Net Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.56
FY2025
5-year range
-$0.49 / $2.62
FY2021-FY2025
Trend
+51.2%
vs FY2024
Sector context
#41 of 82
Health Care
What the data says
At $0.56, Arcutis Biotherapeutics, Inc.'s net debt per share ranks #42 of 82 in the Health Care sector. Net Debt per Share returned to growth in FY2025 after 2 years of decline, reaching $0.56.
Based on SEC 10-K filings.
0.56 in FY2025 with a 3-year CAGR of -40.2%.
Improved from $1.64 to $0.56 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -40.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#42 of 82 in Health CareTop 50% of 82This company $0.56 Sector average $1.13
▼
-50.4% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 51.2% year-over-year.
- Ranks #41 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2022.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.56 | +51.2% |
| FY2024 | $0.37 | -77.4% |
| FY2023 | $1.64 | -37.5% |
| FY2022 | $2.62 | +636.9% |
| FY2021 | -$0.49 | +73.3% |
| FY2020 | -$1.82 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026